Medical marijuana for the treatment of vismodegib-related muscle spasm.

Yuan, Joyce T; Tello, Tiffany L; Hultman, Carter; Barker, Christopher A; Arron, Sarah T; Yom, Sue S

Yuan, Joyce T; Tello, Tiffany L; Hultman, Carter; Barker, Christopher A; Arron, Sarah T; Yom, Sue S.

Afiliação

Yuan JT; Department of Dermatology, University of California, San Francisco, San Francisco, California.
Tello TL; Department of Dermatology, University of California, San Francisco, San Francisco, California.
Hultman C; Department of Radiation Oncology, University of California, San Francisco, San Francisco, California.
Barker CA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Arron ST; Department of Dermatology, University of California, San Francisco, San Francisco, California.
Yom SS; Department of Radiation Oncology, University of California, San Francisco, San Francisco, California.

JAAD Case Rep ; 3(5): 438-440, 2017 Sep.

Article em En | MEDLINE | ID: mdl-28932790

Palavras-chave

BCC, basal cell carcinoma; CBD, cannabidiol; FDA, US Food and Drug Administration; MM, medical marijuana; THC, tetrahydrocannabinol; basal cell carcinoma; mS, multiple sclerosis; medical marijuana; muscle cramps; vismodegib

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: JAAD Case Rep Ano de publicação: 2017 Tipo de documento: Article